Skip to main content

Advertisement

SpringerLink
Log in

Metabolic syndrome and stroke

  • Published:
Current Diabetes Reports Aims and scope Submit manuscript

Abstract

The metabolic syndrome is highly prevalent worldwide, and its cardiovascular toll is expected to rise with the growing obesity epidemic. Mounting evidence points to an association between metabolic syndrome and first or recurrent stroke. This article discusses the emerging data supporting a link between stroke and the metabolic syndrome and underscores the need to better understand the syndrome’s pathophysiology, with a goal to appropriately and intensively limit the burden of this multiple risk factor entity.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Alberts MJ, Ovbiagele B: Current strategies for ischemic stroke prevention: role of multimodal combination therapies. J Neurol 2007, 254:1414–1426.

    Article  PubMed  CAS  Google Scholar 

  2. Ogden CL, Carroll MD, Curtin LR, et al.: Prevalence of overweight and obesity in the United States, 1999–2004. JAMA 2006, 295:1549–1555.

    Article  PubMed  CAS  Google Scholar 

  3. Grundy SM: Metabolic syndrome: connecting and reconciling cardiovascular and diabetes worlds. J Am Coll Cardiol 2006, 47:1093–1100.

    Article  PubMed  CAS  Google Scholar 

  4. Grundy SM, Cleeman JI, Daniels SR, et al.: Diagnosis and management of the metabolic syndrome. An American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Executive summary. Cardiol Rev 2005, 13:322–327.

    PubMed  Google Scholar 

  5. Gami AS, Witt BJ, Howard DE, et al.: Metabolic syndrome and risk of incident cardiovascular events and death: a systematic review and meta-analysis of longitudinal studies. J Am Coll Cardiol 2007, 49:403–414.

    Article  PubMed  CAS  Google Scholar 

  6. IDF. The IDF consensus worldwide definition of the metabolic syndrome. Available at http://www.idf.org/webdata/docs/IDF_Meta_def_final.pdf. Accessed October 13, 2007.

  7. Ford ES, Giles WH, Dietz WH: Prevalence of the metabolic syndrome among US adults: findings from the third National Health and Nutrition Examination Survey. JAMA 2002, 287:356–359.

    Article  PubMed  Google Scholar 

  8. Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report [no authors listed]. Circulation 2002, 106:3143–3421.

  9. Sacco RL, Benson RT, Kargman DE, et al.: High-density lipoprotein cholesterol and ischemic stroke in the elderly: the Northern Manhattan Stroke Study. JAMA 2001, 285:2729–2735.

    Article  PubMed  CAS  Google Scholar 

  10. Kernan WN, Inzucchi SE, Viscoli CM, et al.: Impaired insulin sensitivity among nondiabetic patients with a recent TIA or ischemic stroke. Neurology 2003, 60:1447–1451.

    PubMed  CAS  Google Scholar 

  11. Kernan WN, Inzucchi SE, Viscoli CM, et al.: Insulin resistance and risk for stroke. Neurology 2002, 59:809–815.

    PubMed  CAS  Google Scholar 

  12. Bonora E, Tessari R, Micciolo R, et al.: Intimal-medial thickness of the carotid artery in nondiabetic and NIDDM patients. Relationship with insulin resistance. Diabetes Care 1997, 20:627–631.

    Article  PubMed  CAS  Google Scholar 

  13. Agewall S, Fagerberg B, Attvall S, et al.: Carotid artery wall intima-media thickness is associated with insulin-mediated glucose disposal in men at high and low coronary risk. Stroke 1995, 26:956–960.

    PubMed  CAS  Google Scholar 

  14. Howard G, O’Leary DH, Zaccaro D, et al.: Insulin sensitivity and atherosclerosis. The Insulin Resistance Atherosclerosis Study (IRAS) Investigators. Circulation 1996, 93:1809–1817.

    PubMed  CAS  Google Scholar 

  15. Suzuki M, Shinozaki K, Kanazawa A, et al.: Insulin resistance as an independent risk factor for carotid wall thickening. Hypertension 1996, 28:593–598.

    PubMed  CAS  Google Scholar 

  16. Laakso M, Sarlund H, Salonen R, et al.: Asymptomatic atherosclerosis and insulin resistance. Arterioscler Thromb 1991, 11:1068–1076.

    PubMed  CAS  Google Scholar 

  17. Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group [no authors listed]. Lancet 1998, 352:854–865.

  18. Minamikawa J, Tanaka S, Yamauchi M, et al.: Potent inhibitory effect of troglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 1998, 83:1818–1820.

    Article  PubMed  CAS  Google Scholar 

  19. Koshiyama H, Shimono D, Kuwamura N, et al.: Rapid communication: inhibitory effect of pioglitazone on carotid arterial wall thickness in type 2 diabetes. J Clin Endocrinol Metab 2001, 86:3452–3456.

    Article  PubMed  CAS  Google Scholar 

  20. Suk SH, Sacco RL, Boden-Albala B, et al.: Abdominal obesity and risk of ischemic stroke: the Northern Manhattan Stroke Study. Stroke 2003, 34:1586–1592.

    Article  PubMed  Google Scholar 

  21. Pearson TA, Mensah GA, Alexander RW, et al.: Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 2003, 107:499–511.

    Article  PubMed  Google Scholar 

  22. Ridker PM, Buring JE, Cook NR, Rifai N: C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events: an 8-year follow-up of 14,719 initially healthy American women. Circulation 2003, 107:391–397.

    Article  PubMed  Google Scholar 

  23. Park JH, Kwon HM, Roh JK: Metabolic syndrome is more associated with intracranial atherosclerosis than extracranial atherosclerosis. Eur J Neurol 2007, 14:379–386.

    Article  PubMed  Google Scholar 

  24. Golden SH, Folsom AR, Coresh J, et al.: Risk factor groupings related to insulin resistance and their synergistic effects on subclinical atherosclerosis: the atherosclerosis risk in communities study. Diabetes 2002, 51:3069–3076.

    Article  PubMed  CAS  Google Scholar 

  25. Bonora E, Kiechl S, Willeit J, et al.: Carotid atherosclerosis and coronary heart disease in the metabolic syndrome: prospective data from the Bruneck study. Diabetes Care 2003, 26:1251–1257.

    Article  PubMed  Google Scholar 

  26. Park K, Yasuda N, Toyonaga S, et al.: Significant association between leukoaraiosis and metabolic syndrome in healthy subjects. Neurology 2007, 69:974–978.

    Article  PubMed  CAS  Google Scholar 

  27. Ninomiya JK, L’Italien G, Criqui MH, et al.: Association of the metabolic syndrome with history of myocardial infarction and stroke in the Third National Health and Nutrition Examination Survey. Circulation 2004, 109:42–46.

    Article  PubMed  Google Scholar 

  28. Shah IM, Ghosh SK, Collier A: Stroke presentation in Type 2 diabetes and the metabolic syndrome. Diabetes Res Clin Pract 2007, [Epub ahead of print.]

  29. Ovbiagele B, Saver JL, Lynn MJ, Chimowitz M: Impact of metabolic syndrome on prognosis of symptomatic intracranial atherostenosis. Neurology 2006, 66:1344–1349.

    Article  PubMed  Google Scholar 

  30. Bang OY, Kim JW, Lee JH, et al.: Association of the metabolic syndrome with intracranial atherosclerotic stroke. Neurology 2005, 65:296–298.

    Article  PubMed  CAS  Google Scholar 

  31. Chobanian AV, Bakris GL, Black HR, et al.: The Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report. JAMA 2003, 289:2560–2572.

    Article  PubMed  CAS  Google Scholar 

  32. Knowler WC, Barrett-Connor E, Fowler SE, et al.: Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002, 346:393–403.

    Article  PubMed  CAS  Google Scholar 

  33. Boden-Albala B: Current understanding of multiple risk factors as the metabolic syndrome: distillation or deconstruction. Semin Neurol 2006, 26:108–116.

    Article  PubMed  Google Scholar 

  34. Takahashi K, Bokura H, Kobayashi S, et al.: Metabolic syndrome increases the risk of ischemic stroke in women. Intern Med 2007, 46:643–648.

    Article  PubMed  Google Scholar 

  35. Wannamethee SG, Shaper AG, Lennon L, Morris RW: Metabolic syndrome vs Framingham Risk Score for prediction of coronary heart disease, stroke, and type 2 diabetes mellitus. Arch Intern Med 2005, 165:2644–2650.

    Article  PubMed  Google Scholar 

  36. Najarian RM, Sullivan LM, Kannel WB, et al.: Metabolic syndrome compared with type 2 diabetes mellitus as a risk factor for stroke: the Framingham Offspring Study. Arch Intern Med 2006, 166:106–111.

    Article  PubMed  Google Scholar 

  37. McNeill AM, Rosamond WD, Girman CJ, et al.: The metabolic syndrome and 11-year risk of incident cardiovascular disease in the atherosclerosis risk in communities study. Diabetes Care 2005, 28:385–390.

    Article  PubMed  Google Scholar 

  38. Despres JP, Golay A, Sjostrom L: Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia. N Engl J Med 2005, 353:2121–2134.

    Article  PubMed  CAS  Google Scholar 

  39. Pi-Sunyer FX, Aronne LJ, Heshmati HM, et al.: Effect of rimonabant, a cannabinoid-1 receptor blocker, on weight and cardiometabolic risk factors in overweight or obese patients: RIO-North America: a randomized controlled trial. JAMA 2006, 295:761–775.

    Article  PubMed  CAS  Google Scholar 

  40. Van Gaal LF, Rissanen AM, Scheen AJ, et al.: Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study. Lancet 2005, 365:1389–1397.

    Article  PubMed  Google Scholar 

  41. Orchard TJ, Temprosa M, Goldberg R, et al.: The effect of metformin and intensive lifestyle intervention on the metabolic syndrome: the Diabetes Prevention Program randomized trial. Ann Intern Med 2005, 142:611–619.

    PubMed  CAS  Google Scholar 

  42. He K, Liu K, Daviglus ML, et al.: Magnesium intake and incidence of metabolic syndrome among young adults. Circulation 2006, 113:1675–1682.

    Article  PubMed  CAS  Google Scholar 

  43. Szapary PO, Bloedon LT, Samaha FF, et al.: Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome. Arterioscler Thromb Vasc Biol 2006, 26:182–188.

    Article  PubMed  CAS  Google Scholar 

  44. Vitale C, Mercuro G, Castiglioni C, et al.: Metabolic effect of telmisartan and losartan in hypertensive patients with metabolic syndrome. Cardiovasc Diabetol 2005, 4:6.

    Article  PubMed  Google Scholar 

  45. Thoenes M, Oguchi A, Nagamia S, et al.: The effects of extended-release niacin on carotid intimal media thickness, endothelial function and inflammatory markers in patients with the metabolic syndrome. Int J Clin Pract 2007, 61:1942–1948.

    Article  PubMed  CAS  Google Scholar 

  46. Wilding J, Van Gaal L, Rissanen A, et al.: A randomized double-blind placebo-controlled study of the long-term efficacy and safety of topiramate in the treatment of obese subjects. Int J Obes Relat Metab Disord 2004, 28:1399–1410.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Stroke and Critical Care, Department of Neurology, University of Southern California, 1510 San Pablo Street, HCC 643, Los Angeles, CA, 90033, USA

    Amytis Towfighi

Authors
  1. Amytis Towfighi
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Bruce Ovbiagele
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Amytis Towfighi.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Towfighi, A., Ovbiagele, B. Metabolic syndrome and stroke. Curr Diab Rep 8, 37–41 (2008). https://doi.org/10.1007/s11892-008-0008-z

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11892-008-0008-z

Keywords

Search

Navigation